Related Experiment Videos
Is there a correlation between raised erythropoietin and thrombotic events in sickle-cell anaemia?
1Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City 73190, USA.
Insights
Erythropoietin may increase stroke risk in children with sickle-cell anaemia by making platelets more reactive. This could explain the higher incidence of thrombotic strokes in these young patients.
Area of Science:
- Hematology
- Pediatric Medicine
- Vascular Biology
Background:
- Children with sickle-cell anaemia (SCA) have a high risk of thrombotic strokes.
- The exact cause of these strokes in SCA patients remains unclear.
Purpose of the Study:
- To investigate the role of erythropoietin (EPO) in potentiating thrombotic events in SCA.
- To explore the hypothesis that EPO-induced changes in platelet reactivity contribute to stroke risk in children with SCA.
Main Methods:
- Review of existing literature on EPO, platelet function, and thrombosis in SCA.
- Analysis of animal studies demonstrating EPO's effect on platelet synthesis and reactivity.
- Comparison of EPO levels and stroke incidence in children versus adults with SCA.
Main Results:
- EPO stimulates platelet production and enhances platelet reactivity.
- EPO-driven platelets are hyper-reactive compared to control platelets.
- EPO administration is associated with an increased thrombosis rate.
Conclusions:
- EPO-dependent alterations in platelet reactivity may increase thrombosis risk in SCA.
- Children with SCA exhibit higher EPO concentrations and stroke incidence, supporting this hypothesis.
Abstract:
Children with sickle-cell anaemia are predisposed to thrombotic strokes, the aetiology of which is unclear. We propose that erythropoietin, produced in response to chronic anaemia, is responsible for changes in platelet reactivity with a resulting increase in thromboses. This hypothesis is based on reports of enhanced aggregability of erythropoietin-driven platelets and an increased rate of thrombosis in patients receiving large doses of recombinant erythropoietin. Experiments in animals have shown that erythropoietin stimulates synthesis of platelets, that erythropoietin-driven platelets are hyper-reactive compared with age-matched control platelets, and that erythropoietin is pro-thrombotic. These data suggest that erythropoietin-dependent changes in platelet reactivity may potentiate thrombosis in sickle-cell anaemia, particularly in children who, compared with adults, have markedly higher erythropoietin concentrations and incidence of strokes.